CORRIE DONNELL: Open Payments
NPI 1619351012 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 9 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $119 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $129 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: REZDIFFRA, JARDIANCE, FUROSCIX, JYNARQUE, Kerendia, Vanrafia, FARXIGA.
Industry payments across MO — which companies pay providers there.
